Treatment with molnupiravir in the MOVe-In and MOVe-Out clinical trials results in an increase in transition mutations across the SARS-CoV-2 genome
IDWeek 2021 Sept 29-Oct 3
Julie Strizki; Nicholas Murgolo; Ying Zhang; Jiejun Du; Shunbing Zhao; Diane Levitan; Alex Therien; Joan Butterton; Jay Grobler
Merck & Co., Inc., Kenilworth, NJ, USA
